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A case of disseminated nocardiosis caused by Nocardia arthritidis in an immunocompromised patient
with a history of chronic lymphocytic leukemia and rheumatoid arthritis is presented. This report
highlights the use for multilocus sequence typing (MLST) in addition to single gene molecular sequencing
to identify rare Nocardia species.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A 71-year-old Caucasian female with a history of chronic
lymphocytic leukemia (CLL) and rheumatoid arthritis (RA)
presented to her primary care physician with a 2 month history
of worsening cough and dyspnea without fevers, chills or sinus
congestion. She was maintained on a low dose of prednisone
(homeopathic not treatment dose), at 5 mg daily, for treatment of
RA. Four years prior to presentation, she was treated with
chlorambucil for 6 months followed by IV immunoglobulin for
9 months for CLL.
At presentation, the patient underwent a computed tomogra-
phy (CT) scan which showed a 4.5 cm non-calciﬁed solid mass in
the superior segment of the right lower lobe (RLL) followed by an
ultrasound (US) guided needle biopsy. A Gram-stain of the biopsy
showed gram-positive branching, beaded ﬁlamentous bacilli;
however, culture was not performed at this time. The histology
(performed by an outside institution) was originally negative for
both bacterial and fungal elements. The patient was subsequently
treated empirically with 5 weeks of oral levoﬂoxacin (750 mg, once
daily) followed by 2 weeks of oral azithromycin (500 mg daily)
without improvement. Following a continued complaint of* Corresponding author.
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was referred to The Nebraska Medical Center (TNMC) for further
evaluation as an outpatient.
When seen in the TNMC outpatient clinic, the patient appeared
well and her physical examination was normal. The absolute
lymphocyte count was 1300 mL1 (normal 700–3900 mL1).
Repeat CT scan demonstrated enlargement of the RLL mass with
new cavitation. A CT-guided ﬁne-needle biopsy of the RLL mass
was performed 5 days prior to inpatient admission. Histological
exam of the tissue revealed organizing acute and chronic
inﬂammation which was reported negative for bacteria by Fite-
Faraco modiﬁed acid fast (FITE) stain and negative for bacterial and
for fungal elements by the Gomori methenamine-silver (GMS)
stain. Five days later the patient developed fever, chills and
dyspnea and was admitted to TNMC (day 0, post-admission (PA)).
The RLL biopsy tissue subsequently became culture positive for a
Nocardia species 8 days after culture on Sabouraud dextrose agar
(SAB). The FITE stain of the TNMC RLL ﬁne-needle biopsy was
subsequently re-reviewed at 1000 magniﬁcation and determined
to be positive for rare long thin branching ﬁlamentous bacilli that
were modiﬁed acid-fast negative. Consequently the histology stain
report was amended to state, “morphologically consistent with
nocardiosis.” The re-reviewed GMS-stained biopsy remained
negative for bacterial and fungal elements.
Empiric antibacterial and antifungal agents were discontinued
and high-dose oral trimethoprim-sulfamethoxazole (TMP-STX)
(2 double-strength tablets (800 mg/160 mg), twice a day) wasder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The MRI detected multiple intracerebral multifocal ring enhancing lesions,
indicative of nocardiosis (A, B).
Table 1
Nocardia species included in the MLST phylogenetic analysis.
Species Strain Name Accession Numbera
Nocardia arthritidis NBRC 100137 BDBB01000084.1
Nocardia beijingensis NBRC 16342 BDBC01000022.1
Nocardia brasiliensis ATCC 700358 NC_018681.1
Nocardia brevicatena NBRC 12119 NZ_BAFU01000024.1
Nocardia cyriacigeorgica GUH-2 NC_016887.1
Nocardia exalbida NBRC 100660 NZ_BAFZ01000028.1
Nocardia farcinica IFM 10152 NC_006361.1
Nocardia gamkensis NBRC 108242 BDBM01000066.1
Nocardia pneumoniae NBRC 100136 NZ_BAGF01000021.1
Nocardia tenerifensis NBRC 101015 NZ_BAGH01000146.1
a Gene sequences were extracted from publicly available genomes in the
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the neurologic exam was normal, a magnetic resonance imaging
(MRI) of the brain was performed due to the known propensity for
Nocardia species to disseminate to the central nervous system
(CNS) in immunocompromised individuals. The MRI detected
multiple intracerebral multifocal ring enhancing lesions, indicative
of nocardiosis (Fig. 1A, B). On day 4 PA, the patient developed a
nodular lesion on the lower right leg. Biopsy of this leg lesion and
histologic staining again showed the presence of modiﬁed acid-
fast stain negative branching ﬁlamentous bacteria, subsequently
identiﬁed in culture as Nocardia species. The patient was treated
with a course of oral TMP-STX for a planned minimum of
12 months, in conjunction with IV ceftriaxone (2 g every 12 h)
for the initial 3 months. Serum sulfamethoxazole levels were
maintained at 12–16 mg/dL range over the duration of therapy.
A marked improvement of pulmonary symptoms and a
decrease in the size of the brain lesions as observed by MRI after
12 weeks of combination therapy was noted. The patient continued
to improve and never developed neurologic symptoms. MRI of the
brain after one year of treatment with high-dose oral TMP-STX
showed resolution of the abscesses and the drug was discontinued.
Two months later she had a sudden syncope episode and although
no changes were seen on repeat brain MRI, oral TMP-SMX was re-
instituted for chronic maintenance therapy.
Materials and methods
To determine the Nocardia species and to obtain the antimicro-
bial susceptibility testing (AST) proﬁle, two isolates (SQ-14-
947 and SQ-14-948) were submitted to an outside reference
laboratory for testing (ARUP Laboratories, Salt Lake City, UT).
Sequence analysis of the partial 16S rRNA target identiﬁed the
isolates as Nocardia abscessus complex/Nocardia gamkensis. The
AST minimum inhibitory concentration (MIC (mg/mL)) results for
both case isolates were: amoxicillin/clavulanate 128/64 (Resis-
tant (RR)); ceftriaxone 4 (Susceptible (SS)); ciproﬂoxacin 8
(RR); clarithromycin 4 (Intermediate); imipenem 4 (SS); tobra-
mycin 1 (SS); and trimethoprim/sulfamethoxazole 0.25/4.8
(SS). The AST proﬁles and the corresponding drug patterns were
inconsistent with the Type I drug susceptibility pattern for N.
abscessus complex [1] and neither a drug pattern nor antimicrobial
susceptibilities had been described for N. gamkensis [2,3].
Interestingly, N. gamkensis has yet to be reported in association
with human disease, with the original isolates being discovered in
soil removed from the Gamka River in Western Cape Province,
South Africa [3]. Based on the AST pattern, additional analyses
were pursued to conﬁrm the species level identiﬁcation. Moreover,
multiple reports have shown that the partial 16S rRNA gene
sequence could not differentiate between Nocardia exalbida and
Nocardia gamkensis [1,4–8].To further evaluate the species identiﬁcation, the complete 16S
rRNA gene as well as the secA, gene and hsp65 gene were sequenced
and analyzed by the Mycobacterial/Nocardia Research Reference
Lab at the University of Texas Health Science Center at Tyler
(UTHSCT, CLIA regulated). Each gene was sequenced and analyzed
per the UTHSCT standard protocol [5,9,10]. The sequence analysis
results showed that the complete 16S rRNA gene resulted in 99.9%
match (1391/1392 bp) to N. arthritidis type strain, 99.5% match
(1406/1413 bp) to N. araoensis type strain, and 99.0% match (1399/
1413) to N. exalbida type strains for both isolates. All of these
species belong to or are closely associated with N. abscessus
complex. The CLSI recommends that 99.6% identity occur to
conﬁrm for genus and the species identiﬁcation [10]. SecA1 amino
acid analysis of secA1 gene sequencing provided a 100% match to N.
arthritidis and N. exalbida type strains and 99.36% match to N.
araoensis type strain giving a ﬁnal identiﬁcation of Nocardia
arthritidis/exalbida/araoensis. For Nocardia,secA1 has been the
preferred gene for sequencing, and for 0–1 amino acid mis-match
corresponding to 99% identity consider reporting the conﬁrmed
genus and species [5]. Finally, hsp65 gene sequencing resulted in a
98.8% match (417/422 bp) to N. arthritidis type strain, 98.3% match
(393/400 bp) to N. exalbida type strain and 97.4% match
(411/422 bp) to N. araoensis. There are currently no CLSI guidelines
for the interpretation of hsp65 gene sequences in Nocardia species.
To improve on the resolution of the single gene sequencing
results, a multi locus strain typing (MLST) approach was performed
for all three gene targets (16S rRNA, hsp65 and secA). Gene
sequence data for the 3 loci were extracted for 10 diverse Nocardia
species (Table 1) from the prokaryotic genome database at the
National Center for Biotechnology Information (NCBI), and
sequences were concatenated for each species. Then, neighbor
joining phylogenetic analyses [11] with 100 replicate searches
were performed for each gene separately and the concatenated
sequences (MLST) for all 12 strains using the SeaView software
package [27]. The results following analysis showed that for
Phylogenies: 1.) for the individual gene analyses, 2 of the 3 genes
(16S rRNA and hsp65) suggested that SQ-14-947 and SQ-14-948 are
most closely related to Nocardia arthriditis while secA1 supported
placement next to N. exalbida and N. gamkensis. Both of these trees,
however, had low bootstrap support (<50) at the basal nodes
indicating unreliable branching patterns (Fig. 2A). 2.) For the MLST
analysis, the bootstrap support values were > = 57 at all nodes, and
SQ-14-947 and SQ-14-948 are monophyletic with Nocardia
arthriditis (Fig. 2B). The 16S rRNA alignment contained only 49
informative positions (out of 1489 total positions) while the
MLST consensus sequence alignment contained 123 informative
positions (out of 2375 total positions) illustrating the increased
resolution of the MLST approach. Pairwise distance comparisons
of concatenated MLST sequences: 1.) SQ-14-947 and SQ-14-
948 isolates were identical (100% identity); 2.) with 12/2389 vari-
able sites between SQ-14-947 and Nocardia arthritidis (99.5%GenBank database at NCBI.
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Fig. 2. Phylogenetic analyses of strains SQ-14-947 and SQ-14-948 compared to 10 diverse Nocardia species. A.) 16S rRNA sequences and B.) concatenated sequences of 16S
rRNA, hsp65 and secA1 were aligned, and phylogenies were constructed with the neighbor joining method. Bootstrap support values of 100 replicate searches are shown at
each node.
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Nocardia gamkensis (99.1% identity); 4.) with 25/2389 variable sites
between SQ-14-947 and Nocardia exalbida (99% identity); and 5.)
with are 38/2389 variable sites between SQ-14-947 and Nocardia
beijingensis (98.4% identity). These results showed via MLST that
both isolates were identiﬁed as Nocardia arthritidis.
Discussion
Greater than 80 valid species of Nocardia have been described
(List of Prokaryotic Names, www.bacterio.net, accessed 22 April
2014), with only 11 species reported as isolated from human
infections to include N. abscessus, N. brasiliensis, N. cyriacigeorgica,
N. farcinica, N. nova, N. otitidiscaviarum, N. paucivorans, N.
pseudobrasiliensis, N. transvalensis, N. veteran, and N. wallacei
[17,18]. Initially, Nocardia species that cause human infection were
typically classiﬁed as N. asteroides or N. asteroides complex. But
with the advent of molecular analysis for more precise identiﬁca-
tion, N. asteroides complex became an obsolete species [1,12].
Overall, Nocardia species are typically associated with environ-
mental sources [13]. The Nocardia species are long thin, ﬁnely
beaded branching gram-positive bacilli that are strict aerobic,
generally modiﬁed acid-fast positive and typically stain positive by
the Gomori methanamine silver (GMS) stain in tissue [4].
Ampliﬁcation and sequencing of individual conserved genes, such
as the 16S rRNA gene, hsp65 gene, secA gene, and gyrB gene have
been used for the identiﬁcation of Nocardia species [1,4,7,14].
Genomic sequencing has led to the discovery of numerous
previously unrecognized or rare Nocardia species that cause
human disease. This report describes a case of disseminated
infection by Nocardia arthritidis within the United States and
highlights the methods used to verify the species identiﬁcation.
Nocardia arthritidis was ﬁrst published as a valid species in
2004 by Kageyama et al., who reported a Japanese patient from
whom N. arthritidis type strain IFM 10035T (NBRC 100137T, JCM
12120T, DSM 44731T) was isolated from the sputum of a patient
with rheumatoid arthritis [15]. This isolate was classiﬁed by the
16S rRNA sequence, DNA–DNA hybridization, and biochemical
phenotypic properties [15]. Since this initial publication, additionalcases caused by N. arthritidis have been reported to include a
recovery of N. arthritidis from a frontal lobe lesion in a patient in
Spain with a history of silicosis [16]; a case of cerebral nocardiosis
in an immunosuppressed patient with systemic lupus erythema-
tosus in Turkey [17]; and a case of N. beijingensis and N. arthritidis
coinfection in a retrotracheal necrotic mass of an immunosup-
pressed patient in Ohio, USA [18]. Each of these reports primarily
utilized 16S rRNA sequencing or species identiﬁcation [16–18].
Conditions that contribute to the risk for nocardiosis include
cellular immune dysfunction, usually due to high-dose steroids,
hematologic malignancy (such as CLL in the patient presented
here), or chronic immune suppression following solid organ
transplantation [19–21] (Rosman article, 21, 22). Chronic obstruc-
tive pulmonary disease may also be a risk factor, and up to a quarter
of nocardiosis cases are noted in immunocompetent individuals
[19,20]. The present case patient was treated with prednisone (5
mg per day) for RA, a dose that is not considered to be
immunosuppressive., although corticosteroid use has been shown
to correlate with the development of pulmonary or disseminated
nocardiosis in 64.5% (n = 20 of 31) of nocardiosis cases [19,20].
Regardless of immune status there is a risk for progression to
disseminated disease in about 30% of all patients with primary
nocardiosis [20]. Disseminated infection is characterized by
abscess formation at multiple body sites with common sites being
the brain, retina, skin, subcutaneous tissue, kidney, bone and heart
[19]. The criteria for disseminated nocardiosis include involvement
of two or more noncontiguous site organs [22]. Nocardia species
reported associated with disseminated nocardiosis included N.
abscessus, N. beijingensis, N. cyriacigeorgica, N. farcinica, N. higoensis,
N. nova, N. otitidiscaviarum, N. paucivorans, N. pseudobrasiliensis and
N. transvalensis [1]. CNS involvement has been noted in 11.7–44% of
systemic nocardiosis cases, usually in the form of one or more brain
abscesses [6,19,23].
In the present case, N. arthritidis was isolated from tissue
obtained from both the lung and leg in pure culture from a febrile
patient with a history of CLL and RA. The original modiﬁed acid fast
(FITE) stain of a ﬁne-needle biopsy of the RLL was reported as
negative for bacteria. Following a positive culture, the original
FITE-stained tissue slides were re-observed using 1000
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negative bacteria were discovered. Due to a lack of contrast
between the organism and background, the organisms were not
visible under 40 magniﬁcation (standard procedure used to
observe histology slides). Over-decolorization during the staining
process of the rare ﬁnely beaded Nocardia cells present in the
sample may also have accounted for the inability to observe the
ﬁlamentous bacteria in the original stain. A positive control slide
(containing a Mycobacterium species) that was used at the time of
staining the original specimen correctly stained as modiﬁed AFB
positive. A modiﬁed Ziehl-Neelsen acid-fast stain performed from
culture of the isolate was also positive. The GMS stained slide of the
original biopsy sample remained negative for both bacteria and
fungal cells after observation under 1000 magniﬁcation. Rare
reports have shown that a negative GMS stain was seen for some
Nocardia species although the reason for this was not elucidated
[24,25].
Molecular sequencing of the variable regions of the16S rRNA
gene, hsp65 gene, secA gene, and gyrB gene targets have been
shown to be discriminatory enough to distinguish among closely
related Nocardia species [1,4–8]. Historically, the AST pattern type
groups were utilized to separate among species and complexes
within the Nocardia genus. The six major drug pattern groups have
been classiﬁed as Types I–VI [1]. As indicated previously, N.
abscessus belongs to the AST pattern designated as Type I; whereas,
N. beijingensis and N. arthritidis do not have ofﬁcially accepted AST
patterns [1,26]. Although the AST patterns for Nocardia can remain
useful in the initial characterization of Nocardia species, incon-
sistencies in this pattern recognition have been noted and are now
used less frequently than molecular methods In conclusion, this
report describes a unique case of disseminated nocardiosis caused
by N. arthritidis. The difﬁculty of recognizing Nocardia species in
tissue and the complexity of methods needed to provide a
conﬁrmed species identiﬁcation were shown. The beneﬁt of
utilizing MLST for difﬁcult to speciate is described in this report.
Increased use of molecular methods and the expansion of mass
spectrometry for identiﬁcation purposes will likely expand the
number of Nocardia species associated with human disease.
Consequently, human infections linked to rarely detected Nocardia
species such as N. arthritidis and newly described species will likely
be encountered more frequently from a wider geographical
distribution. Finally, the observation of tissue following histologi-
cal staining using high-power magniﬁcation is suggested when
negative results are seen from patients who are at high risk for
nocardiosis.
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